对比增强四维双能CT用于胰腺癌靶区勾画的临床实施
本研究对12例胰腺癌患者行对比增强四维双能CT(CE-4D-DECT),通过定量光谱分析确定最佳虚拟单能图像(O-VMI),并比较O-VMI、标准VMI(S-VMI,77 keV)与单能CT(SECT,120 kVp)的图像质量。结果显示O-VMI在胰腺实质与肿瘤的对比噪声比(CNR)、整体图像质量、肿瘤强化及血管显示的主观评分上均优于S-VMI和SECT。
要点
- O-VMI(60 keV)的CNR为3.4,显著高于S-VMI(2.4)和SECT(2.7)(p<0.05)。
- 4名放射肿瘤科医生对O-VMI的整体图像质量、肿瘤强化和血管显示主观评分均高于S-VMI和SECT。
- CE-4D-DECT衍生的O-VMI在显示胰腺肿瘤方面优于S-VMI和SECT。
核心结论
- CE-4D-DECT衍生的最佳虚拟单能图像(O-VMI)在描绘胰腺肿瘤方面优于标准VMI(77 keV)和单能CT(120 kVp)。
研究设计与样本
- 研究纳入12例接受CE-4D-DECT的胰腺癌患者,对虚拟单能图像进行定量光谱分析以确定具有最高对比噪声比(CNR)的最佳VMI(O-VMI)。
- 比较O-VMI、标准VMI(S-VMI,77 keV)和单能CT(SECT,120 kVp)的客观CNR及5分制主观图像质量评分。
主要发现
- CNR在60 keV的VMI中最高,O-VMI的CNR(3.4)显著高于S-VMI(2.4)和SECT(2.7)(p<0.05)。
- 4名放射肿瘤科医生的整体平均主观评分:整体图像质量O-VMI为4.0、S-VMI为3.3、SECT为3.7;肿瘤强化分别为3.4、2.6、3.2;血管显示分别为4.2、3.6、4.2。
关键数值与推荐
- 最佳VMI确定为60 keV,其CNR最高。
- 主观图像质量采用5分制评估。
临床怎么用
- 对于胰腺癌放疗靶区勾画,可采用CE-4D-DECT衍生的O-VMI(60 keV)以提高肿瘤与胰腺实质的对比度及血管显示。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: The accurate delineation of pancreatic tumor with respiratory motion is challenging. This study demonstrates the application of contrast-enhanced four-dimensional dual-energy computed tomography (CE-4D-DECT) for tumor delineation and assesses the objective and subjective image quality. MATERIAL AND METHODS: Twelve patients underwent CE-4D-DECT, and quantitative spectral analysis was performed on the resulting virtual monochromatic images (VMI) to determine the optimal VMI (O-VMI) with the highest contrast-to-noise ratio (CNR). The objective value of the CNR between pancreatic parenchyma and tumor, and the subjective measurement with five-point scale were compared between O-VMI, standard VMI (S-VMI, 77 keV) and single energy CT (SECT, 120 kVp). RESULTS: The CNR was the highest in the VMI at 60 keV, and the corresponding CNR in the O-VMI (3.4) was significantly higher (p < 0.05) than that in the S-VMI (2.4) and the SECT (2.7). The overall mean subjective measurements among 4 radiation oncologists were higher for the O-VMI over the S-VMI and SECT with respect to overall image quality (4.0, 3.3 and 3.7, respectively), tumor enhancement (3.4, 2.6 and 3.2, respectively), and vessel delineation (4.2, 3.6 and 4.2, respectively). CONCLUSIONS: The O-VMI derived from the CE-4D-DECT demonstrated its superiority over the S-VMI and SECT in depicting pancreatic tumor.
引用
- Ohira S, Wada K, Hirata T, et al. Clinical implementation of contrast-enhanced four-dimensional dual-energy computed tomography for target delineation of pancreatic cancer. Radiother Oncol. 2018. PMID: 29422428. doi:10.1016/j.radonc.2018.01.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。